{"companyId":272489,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"アブセレラ バイオロジクス株式会社","headOfficeLocation":"カナダ、バンクーバー、ユーコン通り2215番地、V5Y 0A1","presidentName":"カール・ハンセン","companySummary":null,"stockCode":"ABCL","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["abcellera.com"],"businessContents":["抗体を基盤とした医薬品を発見・開発するための技術プラットフォームを使用しています。"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://abcellera.com/","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}